文献
J-GLOBAL ID:202002254445560856
整理番号:20A0975087
単回投与後の急性発症1型糖尿病を引き起こすニボルマブとイピリムマブによる免疫チェックポイント阻害剤併用療法:2症例報告【JST・京大機械翻訳】
Combined immune checkpoint inhibitor therapy with nivolumab and ipilimumab causing acute-onset type 1 diabetes mellitus following a single administration: two case reports
著者 (7件):
Zezza Marco
(Service of Endocrinology, Diabetes and Metabolism, Lausanne University Hospital (CHUV), University of Lausanne, Lausanne, Switzerland)
,
Kosinski Christophe
(Service of Endocrinology, Diabetes and Metabolism, Lausanne University Hospital (CHUV), University of Lausanne, Lausanne, Switzerland)
,
Mekoguem Carine
(Service of Endocrinology, Diabetes and Metabolism, Lausanne University Hospital (CHUV), University of Lausanne, Lausanne, Switzerland)
,
Marino Laura
(Service of Endocrinology, Diabetes and Metabolism, Lausanne University Hospital (CHUV), University of Lausanne, Lausanne, Switzerland)
,
Chtioui Haithem
(Service of Clinical Pharmacology, Lausanne University Hospital (CHUV), University of Lausanne, Lausanne, Switzerland)
,
Pitteloud Nelly
(Service of Endocrinology, Diabetes and Metabolism, Lausanne University Hospital (CHUV), University of Lausanne, Lausanne, Switzerland)
,
Lamine Faiza
(Service of Endocrinology, Diabetes and Metabolism, Lausanne University Hospital (CHUV), University of Lausanne, Lausanne, Switzerland)
資料名:
BMC Endocrine Disorders (Web)
(BMC Endocrine Disorders (Web))
巻:
19
号:
1
ページ:
1-5
発行年:
2019年
JST資料番号:
U7424A
ISSN:
1472-6823
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
イギリス (GBR)
言語:
英語 (EN)